Cartesian Therapeutics, Inc. — Director's Dealing 2020

Apr 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2020-04-24

Reporting Person: ANDO GORAN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-24	Stock Option (Right to Buy)	$2.67	A	40000	Acquired	2030-04-23	Common Stock (40000.0)	Direct

Footnotes

F1: The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant.